Loading clinical trials...

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT04167514

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Study CSL964\_5001 will investigate the efficacy of AAT with corticosteroids compared with corticosteroids alone as first line therapy for patients with high-risk acute GVHD

Lead sponsor: CSL Behring•25 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

TERMINATEDNA

Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis

NCT01324908 · Graft Versus Host Disease (GVHD)

COMPLETEDNA

University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol

NCT01463475 · Graft Versus Host Disease (GVHD), Acute Myocardial Infarction (AMI)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 29, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment136

Start dateJan 2020

Last updatedAug 29, 2025

Condition

Graft Versus Host Disease (GVHD)

Locations shown

Stanford University

Stanford, California

University of Florida

Gainesville, Florida

Moffitt Cancer Center

Tampa, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 29, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions